Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial

Background There is limited prospective or comparative data evaluating the HRQoL impact of intensive chemotherapy (IC) in older adults (age ≥60 years) with AML. In the recent EA E2906 phase 3 study of '7&3' (daunorubicin & cytarabine) vs. clofarabine (CLO), a putative lower intensi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.594-594
Hauptverfasser:	Foran, James M., Chen, Li, Luger, Selina M, Sun, Zhuoxin, Klepin, Heidi, Claxton, David F., Lazarus, Hillard M., Rowe, Jacob M., Altman, Jessica K., Al-Kali, Aref, Zheng, Hong, Pratz, Keith W, Broun, Edward R., Powell, Bayard L, O'Dwyer, Kristen M., Ofran, Yishai, Godwin, John E., Litzow, Mark R., Tallman, Martin S., Wagner, Lynne
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!